Spyre Therapeutics Inc (FRA:3920)
€ 30.65 1.15 (3.9%) Market Cap: 1.64 Bil Enterprise Value: 1.50 Bil PE Ratio: 0 PB Ratio: 8.15 GF Score: 51/100

Spyre Therapeutics Inc (FRA:3920) Transcripts

  • 1